Conformis
« BACK TO ALL NEWS ARTICLES

Conformis CEO: Getting A Knee Up (Mad Money, CNBC)

Click here to read the full show recap on TheStreet.com

Conformis is not responsible for the contents or reliability of any third-party materials accessible on Conformis’s website, including embedded videos, audio recordings and images, or links to external websites or other third-party materials. The information contained in such third-party materials may not be accurate or current, and Conformis does not necessarily endorse the views expressed within them. Any third-party materials are provided for your convenience and information only.

RELATED POSTS

Related Posts

New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1

Study included only patients with a fully personalized Conformis implant in one knee after previously receiving a competitive off-the-shelf implant

Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel 

Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards 

Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants

A retrospective review of 540 procedures performed demonstrated 98.5% Implant Survivorship and 89.0% Patient Satisfaction for the Conformis patient-specific iTotal®

Contact Us: international@conformis.com